2021
DOI: 10.3389/fnins.2021.695592
|View full text |Cite
|
Sign up to set email alerts
|

Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?

Abstract: Nerve growth factor (NGF) was the first-discovered member of the neurotrophin family, a class of bioactive molecules which exerts powerful biological effects on the CNS and other peripheral tissues, not only during development, but also during adulthood. While these molecules have long been regarded as potential drugs to combat acute and chronic neurodegenerative processes, as evidenced by the extensive data on their neuroprotective properties, their clinical application has been hindered by their unexpected s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 146 publications
(166 reference statements)
2
12
0
Order By: Relevance
“…Precedents for NGF delivery using hydrogels and scaffolds [ 40 ] imply the potential to engineer recombinant silks as substrates for NGF sequestration and delivery. To specifically test for both the accessibility and NGF‐binding competence of the N B motifs in the N B Silk, as implied through the surface localization and observation of dynamics of the N B motifs over MD simulations, steady‐state intrinsic Trp fluorescence spectroscopy was used.…”
Section: Resultsmentioning
confidence: 99%
“…Precedents for NGF delivery using hydrogels and scaffolds [ 40 ] imply the potential to engineer recombinant silks as substrates for NGF sequestration and delivery. To specifically test for both the accessibility and NGF‐binding competence of the N B motifs in the N B Silk, as implied through the surface localization and observation of dynamics of the N B motifs over MD simulations, steady‐state intrinsic Trp fluorescence spectroscopy was used.…”
Section: Resultsmentioning
confidence: 99%
“…Their clinical application is not only limited by the side effect but also the routes of administration and variable bioactivity (52). Alternative approaches, such as small molecule mimetics, topical application and biomaterial-assisted delivery (54), are being developed and may bring a new outlook to the decade-old treatment strategy with neurotrophic factors. Another potential treatment strategy is to stimulate the endogenous overexpression of the neurotrophic factors in a more natural, physiological manner (52).…”
Section: Discussionmentioning
confidence: 99%
“…At the same time, surgery often includes craniotomy and cranioplasty, calling for the need to develop biocompatible materials that can substitute physiological tissues and promote recovery [ 43 , 44 ]. Both of these issues have been under investigation in recent years, leading to the design and formulation of biocompatible scaffolds that allow the prolonged release of therapeutics, along with the promotion of tissue curing [ 45 , 46 ]. In fact, many scaffolds have been developed, using different materials and production techniques ( Table S2 ).…”
Section: Pathologies Of the Central And Peripheral Nervous System And...mentioning
confidence: 99%